SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,472.33 879.09
( 1.23%)

Global Indices

Nasdaq

51,245.91 45.04
(0.09%)

Dow Jones

7,786.38 -36.39
(-0.47%)

Hang Seng

69,084.74 42.63
(0.06%)

Nikkei 225

10,559.70 118.10
(1.13%)

Forex

USD-INR

96.67 0.30
(0.31%)

EUR-INR

108.31 -0.02
(-0.02%)

GBP-INR

127.86 0.18
(0.14%)

JPY-INR

0.61 0.00
(0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

629.4942217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

83.2

249248.45

EPS(TTM)

Face Value()

Div & Yield %

112.85

0.32

Back

pakka ltd

Aditya Birla Capital consolidated net profit rises 40.07% in the June 2026 quarter

Jul 31,2026

Net profit of Aditya Birla Capital rose 40.07% to Rs 1174.70 crore in the quarter ended June 2026 as against Rs 838.63 crore during the previous quarter ended June 2025. Sales rose 28.17% to Rs 12179.54 crore in the quarter ended June 2026 as against Rs 9502.69 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	12179.54	9502.69	28
OPM %	40.71	40.52	-
PBDT	1722.40	1253.23	37
PBT	1640.87	1181.94	39
NP	1174.70	838.63	40

72,472.33 879.09 ( 1.23%)

51,245.91 45.04 (0.09%)

7,786.38 -36.39 (-0.47%)

69,084.74 42.63 (0.06%)

10,559.70 118.10 (1.13%)

96.67 0.30 (0.31%)

108.31 -0.02 (-0.02%)

127.86 0.18 (0.14%)

0.61 0.00 (0.24%)